跳至主要内容
临床试验/NCT06344377
NCT06344377已完成不适用

The Impact of Betaine Supplementation on Body Composition and Lipid Metabolism in a Group of Overweight and Obese Women

Poznan University of Life Sciences2 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2024年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
54
试验地点
2
主要终点
Lipid profile

研究概览

简要总结

Obesity represents a serious global health issue with significant consequences, including an increased risk of chronic diseases. Statistics indicate a growing trend of obesity, highlighting the need to seek methods that improve fat tissue metabolism and reduce obesity-related complications. Previous research on animals has shown that betaine, a substance engaged in one-carbon metabolism, may enhance fat oxidation and lower adipose tissue. Therefore, the aim of the research will be to assess the impact of 8-week betaine supplementation on body composition and lipid metabolism markers, as well as expression of genes related to lipid metabolism, in a group of adult women with abdominal obesity.

This study is designed in a placebo-controlled, double-blinded, randomized fashion. The participants will be overweight or obese pre-menopausal females. Upon enrollment, participants will be randomly assigned to one of two parallel groups: betaine (3g/d) or placebo. The supplementation period will last for 8 weeks. There will be three study meetings: T1 before supplementation, T2 after 4 weeks of supplementation, and T3 after 8 weeks of supplementation. Blood will be drawn and body composition measured, and adipose tissue biopsy taken at meetings T1 and T3. The T2 meeting will involve only body composition measurement. Study outcomes will include body mass and composition (including body fat percent), lipid profile, and the expression of genes related to lipid metabolism in adipose tissue and peripheral blood mononuclear cells.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • age: 18-45 years
  • pre-menopausal
  • overweight or obese: BMI >25 kg/m2
  • waist circumference > 80 cm

排除标准

  • age <18 or >45 years
  • perimenopausal or postmenopausal
  • BMI < 25 kg/m2
  • waist circumference < 80 cm
  • betaine administration for 3 months prior to study
  • pregnant or breastfeeding

结局指标

主要结局

Lipid profile

时间窗: 8 weeks, two measurements: at week 0 and 8

Total cholesterol, Triacylglycerols, LDL-cholesterol, HDL-cholesterol

Body mass

时间窗: 8 weeks, three measurements: at week 0, 4 and 8

Measured in kg

Gene expression

时间窗: 8 weeks, two measurements: at week 0 and 8

Included genes relate to lipid metabolism in adipose tissue: PPARG, CD36, FABP4, UCP1, PPARGC1A, LEP, ADIPOQ, INSR, IRS1, DGAT2, SREBF1, ELOVL5 , FADS3, FASN

Body composition

时间窗: 8 weeks, three measurements: at week 0, 4 and 8

Body composition will include percent body fat and lean body mass measured with air displacement plethysmography

Waist and hips circumference

时间窗: 8 weeks, three measurements: at week 0, 4 and 8

Measured in cm

次要结局

  • Dietary intake(8 weeks, two measurements: at week 0 and 8)
  • sex hormones(8 weeks, two measurements: at week 0 and 8)
  • Liver function test(8 weeks, two measurements: at week 0 and 8)
  • Liver function test(8 weeks, two measurements: at week 0 and 8)
  • Dietary intake(8 weeks, two measurements: at week 0 and 8)
  • sex hormones(8 weeks, two measurements: at week 0 and 8)

研究者

发起方
Poznan University of Life Sciences
申办方类型
Other
责任方
Principal Investigator
主要研究者

Agata Chmurzyńska

Professor

Poznan University of Life Sciences

研究点 (2)

Loading locations...

相似试验